As weight loss drugs soar in popularity, fewer are getting bariatric surgeries

Chief Healthcare Executive October 29, 2024
Ron Southwick

A new study outlines a dramatic increase in patients opting for GLP-1 drugs, and a drop in those opting for surgery to deal with obesity.

More Americans are turning to increasingly popular weight loss drugs, but fewer are choosing surgery to address obesity, researchers have found.

A new study finds a dramatic uptick in the number of people turning to GLP-1 drugs, which are designed for diabetes but have also gained wide appeal for helping people lose weight.

In the last six months of 2023, the number of patients prescribed GLP-1 drugs rose 132.6%, compared to the last six months of 2022, according to findings published Oct. 25 in JAMA Network Open.

At the same time, bariatric surgeries dropped 25.6%...

Today's Sponsors

Today's Sponsor